Patents/Inventors

Boris Engels

Arlington, MAUS12 patents

10 Patents

US125943212026
Bispecific Chimeric Antigen Receptor That Binds CD19 and CD20, Encoding Nucleic Acid Molecules Thereof and Methods of Use Thereof to Treat Cancer
The Trustees Of The University Of Pennsylvania
0 cites
US123836012025
Chimeric Antigen Receptors and Uses Thereof
Novartis AG
0 cites
US123446512025
CD19 and CD22 Chimeric Antigen Receptors and Uses Thereof
Novartis AG
0 cites
US121862782025
Mesothelin Chimeric Antigen Receptor (CAR) and Antibody Against PD-L1 Inhibitor for Combined Use in Anticancer Therapy
President And Fellows Of Harvard College
0 cites
US119997942024
Human Mesothelin Chimeric Antigen Receptors and Uses Thereof
The Trustees Of The University Of Pennsylvania
0 cites
US119817312024
Targeting Cytotoxic Cells with Chimeric Receptors for Adoptive Immunotherapy
Novartis AG
0 cites
US119750262024
CD19 and CD22 Chimeric Antigen Receptors and Uses Thereof
Novartis AG
0 cites
USRE0498472024
Nucleic Acid Molecules Encoding Chimeric Antigen Receptors Comprising a CD20 Binding Domain
The Trustees Of The University Of Pennsylvania
0 cites
US118722492024
Method of Treating Cancer by Administering Immune Effector Cells Expressing a Chimeric Antigen Receptor Comprising a CD20 Binding Domain
The Trustees Of The University Of Pennsylvania
0 cites
US115781302023
Regulatable Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites